Adrenal gland tumor

Search Trials
A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Oct 8, 2011
Disease(s):
Pheochromocytoma
Intervention(s):
131I-MIBG
A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
Status:
Available
Last Changed:
Jan 1, 1970
First Changed:
Oct 1, 2017
Disease(s):
Neuroblastoma
Intervention(s):
131-I-meta-iodobenzylguanidine
18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma
Status:
Recruiting
Last Changed:
Apr 1, 2019
First Changed:
Jan 1, 1970
Disease(s):
Neuroblastoma
Intervention(s):
18F-DA
I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Oct 1, 2008
Disease(s):
Neuroblastoma
Preoperative Alpha Blockade for Pheochromocytoma
Status:
Recruiting
Last Changed:
Apr 6, 2018
First Changed:
May 6, 2017
Disease(s):
Pheochromocytoma
Intervention(s):
PhenoxybenzamineDoxazosin

Connect. Empower. Inspire.